[1] [2] Common examples include semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda)
The higher 3.0 mg and 4.5 mg doses that were approved in 2020 demonstrated hemoglobin A1c reductions closer to 1.5% and slightly more weight loss
Nutrition and lifestyle optimization during retatrutide protocols The peptide creates the metabolic environment
These effects are typically dose-dependent, most prominent during dose escalation, and tend to diminish over time
However, there are several common side effects that many patients report experiencing when they begin using GLP-1 medications
For most people, including those with thyroid conditions (except MTC and MEN2), the benefits of treatment outweigh theoretical thyroid concerns that have not been confirmed in human studies